Osteosarcoma in Korean children and adolescents

Area of Science:

• Oncology
• Orthopedic Surgery
• Pediatric Medicine

Background:

• Osteosarcoma represents the most common primary bone malignancy.
• Significant progress in multimodal treatment strategies has enhanced patient survival.
• Recent decades show marked improvements in osteosarcoma care within Korea.

Purpose of the Study:

• To provide a comprehensive overview of contemporary osteosarcoma treatment modalities utilized in Korea.
• To highlight the advancements in managing osteosarcoma in the Korean pediatric and adolescent population.

Main Methods:

• Review of current therapeutic approaches for osteosarcoma.
• Analysis of treatment outcomes and survival data in the Korean context.

Main Results:

• The 5-year event-free survival rate for localized osteosarcoma in Korean children and adolescents is 64.6%.
• This survival rate is comparable to established benchmarks in American and European patient cohorts.
• Current therapies in Korea reflect advancements in chemotherapy and surgical techniques.

Conclusions:

• Korean osteosarcoma treatment has achieved international standards.
• Continued advancements in combination chemotherapy and surgical interventions are crucial for improving outcomes.
• The findings underscore the effectiveness of current therapeutic strategies for localized osteosarcoma in Korea.